The National Weather Service's Climate Prediction Center says colder-than-normal weather is most likely in the northern and ...
News-Medical.Net on MSN
Eli Lilly’s Adverum move: The future of ocular gene therapy at the 4th Ophthalmic Drug Delivery Summit
The race to develop safer, longer lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery.
The Subject Expert Committee functioning under the Central Drugs Standard Control Organisation (CDSCO) has opined Mankind ...
Next-generation weight loss pills are expected to hit the market next year, and drugmakers are working on medications with ...
Issue 2: Life Support - How Ireland’s FDI base is preparing for the next wave in connected health Advanced optics, lighting, ...
The long-awaited Canadian approval of lecanemab has shifted physicians’ approach to Alzheimer’s disease, addressing previous ...
In a move that could significantly enhance its obesity treatment portfolio, Novo Nordisk has submitted a 7.2 mg formulation of Wegovy for regulatory approval. The submission, accepted for accelerated ...
As the international landscape changes, Ireland’s pharma sector and Government policy need to be agile to maintain competitiveness ...
Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...
Eli Lilly and Co. on Friday, Nov. 21 became the first health care company to surpass a $1 trillion market valuation, driven ...
Three cancer therapies were among the first two batches of drugs to receive vouchers through a new FDA program.
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results